SCM
TWST icon

Sterling Capital Management’s Twist Bioscience TWST Stock Holding History

Sterling Capital Management’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.4K Sell
218
-175
-45% -$11.4K ﹤0.01% 1841
2026
Q1 		$18.7K Hold
393
– – ﹤0.01% 2058
2025
Q4 		$12.5K Buy
393
+250
+175% +$7.8K ﹤0.01% 2496
2025
Q3 		$4.02K Buy
143
+2
+1% +$61 ﹤0.01% 2831
2025
Q2 		$5.19K Buy
141
+80
+131% +$2.76K ﹤0.01% 2498
2025
Q1 		$2.4K Buy
61
+2
+3% +$90 ﹤0.01% 2524
2024
Q4 		$2.74K Hold
59
– – ﹤0.01% 2687
2024
Q3 		$2.67K Buy
+59
New +$2.81K ﹤0.01% 2053

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Sterling Capital Management's TWST Position: Q2 2026 in Review

Sterling Capital Management reduced its Twist Bioscience (TWST) stake by 45% in Q2 2026, selling an estimated $11.4K and leaving 218 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1841.

Sterling Capital Management first reported a position in TWST in Q3 2024 and has held it in 8 quarters since. 335 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Sterling Capital Management held 218 shares of Twist Bioscience worth $22.4K as of Q2 2026.
  • Sterling Capital Management sold 175 Twist Bioscience shares in Q2 2026, an estimated $11.4K.
  • Twist Bioscience made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1841 holding.
  • Sterling Capital Management first reported a position in Twist Bioscience in Q3 2024 and has held it in 8 quarters since.
  • 335 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.